HIV-1 chimpanzee adenovirus vaccine expressing clade C gp140

chimpanzee adenovirus-vectored HIV vaccine expressing clade C gp140 · HIV Vaccine Trials Network

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV-1 chimpanzee adenovirus vaccine expressing clade C gp140, covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult. [Phase 1]

See pricing